Findings of a study comparing waist circumference to BMI for predicting the development of obesity-related cancers show that waist circumference is a stronger risk marker in men but not in women.

The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

With the advent of GLP-1 drugs, perspectives about weight management are changing. Ted Kyle hopes the food industry can make some changes, too, to better serve all consumers.

Novo Nordisk on Monday revealed data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and stoking worries that rival Eli Lilly may be gaining an edge over Novo ...

Refined grains, potatoes and sugary drinks can pack on extra pounds and cause blood sugar to spike, researchers noted. As a ...

In conclusion, this study shows that being overweight or obese during childhood may increase the chance of developing COPD ...

The administration is reviewing a Centers for Medicare and Medicaid Services rule that would expand coverage to Medicare and Medicaid recipients ...

The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...

GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.